| |
|
Form Serial Number: |
CS20260715E00627 |
| 1.
Date of relevant event: |
10/07/2026
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02186 |
| 4.
Name of listed corporation: |
Luye Pharma Group Ltd. |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
3,994,515,953 |
| 7.
Name of substantial shareholder: |
UBS Group AG |
| 8.
Registered office: |
BAHNHOFSTRASSE 45 8001 ZURICH SWITZERLAND |
| 9.
Principal place of business in Hong Kong: |
52/F TWO INTERNATIONAL FINANCE CENTRE, 8 FINANCE STREET, CENTRAL, HONG KONG |
| 15.
Exchange on which listed: |
SIX Swiss Exchange AG |
| 16.
Name of listed parent and exchange on which parent is listed: |
|
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
| 1113 | The percentage level of your interest in the shares has increased because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
|
| 2201 | Interest of corporation controlled by you |
|
18,031,250 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 514,422,261 | 12.88 |
| Short position | 472,699,148 | 11.83 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 532,453,511 | 13.33 |
| Short position | 472,699,148 | 11.83 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| 2201 | Interest of corporation controlled by you |
| | Long position | 532,453,511 | | Short position | 472,699,148 |
|
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| 4103 | Listed derivatives - Convertible instruments |
| | Long position | 210,802,052 | | Short position | 125,787,232 |
|
| 4105 | Unlisted derivatives - Physically settled |
| | Long position | 142,468,000 | | Short position | 142,468,000 |
|
| 4106 | Unlisted derivatives - Cash settled |
| | Long position | 88,250,750 | | Short position | 6,306,183 |
|
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| UBS Fund Management (Switzerland) AG | Aeschenvorstadt 1 ,Basel ,Switzerland ,4051 | UBS Group AG | 100.00 | Y | | Long position | 2,727,500 | | Short position | 0 |
|
| UBS AG | Bahnhofstrasse 45,Zurich,Switzerland,8001 | UBS Group AG | 100.00 | Y | | Long position | 488,940,437 | | Short position | 472,699,148 |
|
| UBS Switzerland AG | Bahnhofstrasse 45,Zurich,Switzerland,8001 | UBS Group AG | 100.00 | Y | | Long position | 1,725,574 | | Short position | 0 |
|
| UBS Europe SE | Bockenheimer Landstrasse 2-4 OpernTurm, Frankfurt am Main Germany, 60306 | UBS Group AG | 100.00 | Y | | Long position | 39,060,000 | | Short position | 0 |
|
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| | | |
|
| |
| 27.
Supplementary information: |
218,500,000 of the reported long and short positions refer to the securities lending agreement executed in conjunction with the convertible bond issuance on June 10th 2026.Disclosure for long positions triggered as cash settled instruments satisfy the inclusion criteria.
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 2: |
15/07/2026
(dd/mm/yyyy)
|
|
|
|
|